Treatment With Liraglutide Exerts Neuroprotection After Hypoxic–Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment With Liraglutide Exerts Neuroprotection After Hypoxic–Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-30
DOI
10.3389/fncel.2019.00585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-dose oral copper treatment changes the hippocampal phosphoproteomic profile and perturbs mitochondrial function in a mouse model of Alzheimer's disease
- (2019) Chongyang Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia
- (2019) A.L. Solevåg et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pretreatment of Grape Seed Proanthocyanidin Extract Exerts Neuroprotective Effect in Murine Model of Neonatal Hypoxic-ischemic Brain Injury by Its Antiapoptotic Property
- (2019) Xing Tu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- FGF21 promotes functional recovery after hypoxic-ischemic brain injury in neonatal rats by activating the PI3K/Akt signaling pathway via FGFR1/β-klotho
- (2019) Lixia Ye et al. EXPERIMENTAL NEUROLOGY
- Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus
- (2018) Rui-Fang Wang et al. EPILEPSY RESEARCH
- Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats
- (2018) Ilijana Babic et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats
- (2018) Ying Yang et al. Molecular Medicine Reports
- Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic–Ischemic Brain Injury
- (2018) Liu Tu et al. NEUROCHEMICAL RESEARCH
- Practice pearl: liraglutide and cardiovascular and renal events in type 2 diabetes
- (2018) Robert Guthrie POSTGRADUATE MEDICINE
- GSK3β Regulates Brain Energy Metabolism
- (2018) Stephen A. Martin et al. Cell Reports
- Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
- (2018) Gül Bahtiyar et al. Current Diabetes Reports
- Methylene blue offers neuroprotection after intracerebral hemorrhage in rats through the PI3K/Akt/GSK3β signaling pathway
- (2018) Chunli Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Isoliquiritigenin protects against blood‑brain barrier damage and inhibits the secretion of pro-inflammatory cytokines in mice after traumatic brain injury
- (2018) Man Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Baicalin protects neonatal rat brains against hypoxic-ischemic injury by upregulating glutamate transporter 1 via the phosphoinositide 3-kinase/protein kinase B signaling pathway
- (2017) Xiao-hua Yan et al. Neural Regeneration Research
- Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats
- (2017) Wenbin Dong et al. NEUROSCIENCE LETTERS
- Therapeutic hypothermia for neonates with hypoxic ischemic encephalopathy
- (2017) Ming-Chou Chiang et al. Pediatrics and Neonatology
- Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study
- (2017) Hitoshi Ishii et al. Diabetology & Metabolic Syndrome
- Liraglutide activates autophagy via GLP-1R to improve functional recovery after spinal cord injury
- (2017) Jian Chen et al. Oncotarget
- Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease
- (2017) Ghada A. Badawi et al. INFLAMMOPHARMACOLOGY
- Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
- (2017) Michael Gejl et al. Scientific Reports
- Omega-3 polyunsaturated fatty acids mitigate blood–brain barrier disruption after hypoxic–ischemic brain injury
- (2016) Wenting Zhang et al. NEUROBIOLOGY OF DISEASE
- Pramipexole-Induced Hypothermia Reduces Early Brain Injury via PI3K/AKT/GSK3β pathway in Subarachnoid Hemorrhage rats
- (2016) Junwei Ma et al. Scientific Reports
- Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1
- (2016) Jenq-Lin Yang et al. Theranostics
- Plasticity in the Neonatal Brain following Hypoxic-Ischaemic Injury
- (2016) Eridan Rocha-Ferreira et al. NEURAL PLASTICITY
- The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways
- (2016) Huili Zhu et al. Scientific Reports
- Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice
- (2015) Yazhou Li et al. JOURNAL OF NEUROCHEMISTRY
- The role of inflammation in perinatal brain injury
- (2015) Henrik Hagberg et al. Nature Reviews Neurology
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Hypoxic-Ischemic Encephalopathy
- (2015) Martha Douglas-Escobar et al. JAMA Pediatrics
- Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
- (2015) Simon C. Cork et al. Molecular Metabolism
- Preservation of the Blood Brain Barrier and Cortical Neuronal Tissue by Liraglutide, a Long Acting Glucagon-Like-1 Analogue, after Experimental Traumatic Brain Injury
- (2015) Jakob Hakon et al. PLoS One
- GLP-1 improves neuropathology after murine cold lesion brain trauma
- (2015) Brian DellaValle et al. Annals of Clinical and Translational Neurology
- Dexamethasone-induced neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation
- (2014) Yangzheng Feng et al. BRAIN RESEARCH
- Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus
- (2014) Lesley J. Scott DRUGS
- Mechanisms of Perinatal Arterial Ischemic Stroke
- (2014) David Fernández-López et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
- (2014) Paula L. McClean et al. NEUROPHARMACOLOGY
- Inflammatory responses in hypoxic ischemic encephalopathy
- (2013) Fudong Liu et al. ACTA PHARMACOLOGICA SINICA
- Mechanisms of Neuroprotection from Hypoxia-Ischemia (HI) Brain Injury by Up-regulation of Cytoglobin (CYGB) in a Neonatal Rat Model
- (2013) Shu-Feng Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
- (2013) Bridgette D. Semple et al. PROGRESS IN NEUROBIOLOGY
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
- (2012) Kerry Hunter et al. BMC NEUROSCIENCE
- Neuronal cell death in neonatal hypoxia-ischemia
- (2011) Frances J. Northington et al. ANNALS OF NEUROLOGY
- Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production
- (2011) Alessandra Valerio et al. JOURNAL OF NEUROCHEMISTRY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
- (2009) Alison Hamilton et al. NEUROREPORT
- Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy
- (2009) Denis V. Azzopardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Spectrum of Abnormal Neurologic Outcomes Subsequent to Term Intrapartum Asphyxia
- (2009) Nabil Al-Macki et al. PEDIATRIC NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started